XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Equity Method Investment (Tables)
6 Months Ended
Jun. 30, 2024
Equity Method Investment  
Schedule of financial information of Angel Pharmaceuticals Co.

As of

As of

Balance Sheet Data

    

June 30, 2024

December 31, 2023

 

(in thousands)

Current assets

$

16,205

$

17,628

Non-current assets

 

1,192

 

1,427

Current liabilities

 

1,028

 

1,725

Non-current liabilities

 

531

 

648

Stockholders' equity

15,838

16,682

Three Months Ended

Six Months Ended

June 30,

June 30,

Statement of Operations Data

    

2024

2023

2024

2023

 

(in thousands)

Revenue

$

$

$

$

Gross Profit

 

 

 

 

Net income (loss)

(677)

(1,620)

(432)

(3,549)

Share of loss from investments accounted for using the equity method

 

(577)

 

(1,284)

 

(341)

 

(3,015)